PrEParing for Lenacapavir Implementation in Your Clinic: Early Lessons Learned

PrEParing for Lenacapavir Implementation in Your Clinic: Early Lessons Learned

On June 18, 2025, the FDA approved Yeztugo, the brand name for subcutaneous lenacapavir, a prescription medication used for the pre-exposure prophylaxis of HIV. Subcutaneous lenacapavir is administered twice a year (every six months) to reduce the risk of sexually acquired HIV-1 infection in adults and adolescents at risk. With patients only needing lenacapavir twice a year for HIV prevention, the field has been optimistic about the potential for lenacapavir to reduce barriers and improve access to PrEP. Since we are still early in the rollout subcutaneous lenacapavir, many providers have questions about how to offer it to their patients—from workflow to billing to managing potential side effects and drug-drug interactions.

On this episode, Antonio Urbina, MD, Medical Director for CEI’s HIV Primary Care and Prevention Center of Excellence, speaks with Alex Danforth, PharmD. Alex Danforth is a clinical pharmacist in Rochester, NY. She practices at Trillium Health, a federally qualified health center, where she works with patients and providers to help manage medications and optimize care. Alex currently provides clinical leadership for HIV treatment and prevention programs.

Drs. Urbina and Danforth talk about the latest New York State Clinical Guidelines for PrEP, which were updated on October 16th. The new guidelines provide important updates, including subcutaneous lenacapavir. They discuss important considerations for initiating patients on lenacapavir as well as some early lessons learned from implementing lenacapavir in their Rochester- and New York City-based clinics. Related Content:

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(67)

Best of the Best: Practice-Changing Papers in STI Care from 2025

Best of the Best: Practice-Changing Papers in STI Care from 2025

Hosts Margie Urban, MD, and Daniela DiMarco, MD, MPH, are joined by Jason Zucker, MD. Dr. Zucker is an Assistant Professor of Medicine at the Columbia University Irving Medical Center and is also the ...

9 Jul 21min

Compassion, Choice and Curiosity: Harm Reduction in Practice

Compassion, Choice and Curiosity: Harm Reduction in Practice

Harm reduction is a set of practical strategies and ideas aimed at reducing negative consequences associated with drug use. It is also a movement for social justice build on a belief in, and respect f...

25 Jun 20min

Closer to a Cure? New HIV Cure Research from Stem Cell Transplants to CAR-T Cell Therapy

Closer to a Cure? New HIV Cure Research from Stem Cell Transplants to CAR-T Cell Therapy

Two recent studies have shown remarkable advances in HIV cure research: (1) a Norwegian man who achieved long-term HIV remission after a stem cell transplant from his brother and (2) a Phase 1 trial t...

11 Jun 10min

ASSETS-NY – Anal Dysplasia Screening, Surveillance, Education and Treatment Services of NY

ASSETS-NY – Anal Dysplasia Screening, Surveillance, Education and Treatment Services of NY

Host Marguerite Urban, MD is joined by William DeWitt, MD, Clinical Director of Anal Health in Primary Care at Northwell Health, to discuss a new coalition forming in New York City about anal dysplasi...

28 Mai 22min

Introducing Point-of-Care Testing for Hepatitis C

Introducing Point-of-Care Testing for Hepatitis C

New York State’s Hepatitis C Dashboard shows that in 2023, 4,783 people were newly diagnosed with HCV in the state, an 8% decrease from 2022. Incidence also decreased, with the rate of new HCV infecti...

14 Mai 21min

Cannabis and Pregnancy

Cannabis and Pregnancy

Based on data from 2023-24, roughly 23% of New Yorkers aged 21 or older reported cannabis use in the past 12 months. Although men generally have a higher prevalence of use than women, recent studies s...

20 Apr 22min

CROI 2026 – Live from Denver: What You Need to Know

CROI 2026 – Live from Denver: What You Need to Know

Conference on Retroviruses and Opportunistic Infections (CROI) 2026 took place from February 22 to 25 in Denver, Colorado. CROI is an annual scientific meeting devoted to the understanding, prevention...

7 Apr 15min

Misconceptions about Contraception

Misconceptions about Contraception

Host Dr. Erica Bostick from the University of Rochester Medical Center Division of Adolescent Medicine chats with Dr. Stacy Sun, a double board-certified physician in obstetrics and gynecology and com...

12 Mar 33min

Populært innen Fakta

fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
foreldreradet
treningspodden
mikkels-paskenotter
rss-kunsten-a-leve
rss-strid-de-norske-borgerkrigene
sinnsyn
hverdagspsyken
rss-sarbar-med-lotte-erik
gravid-uke-for-uke
tomprat-med-gunnar-tjomlid
dopet
fryktlos
rss-kunstig-intelligens-med-elisabeth-maren-og-morten
rss-var-forste-kaffe
tid-for-historie
hva-er-greia-med
jakt-og-fiskepodden